Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


mco1229552226.pdf (1.12 MB)

ETD Abstract Container

Abstract Header

Central Role for Marinobufagenin in the Pathogenesis of Uremic Cardiomyopathy

Vetteth, Sandeep
http://rave.ohiolink.edu/etdc/view?acc_num=mco1229552226

Abstract Details

2008, Doctor of Philosophy in Biomedical Sciences (Ph.D.), University of Toledo, College of Graduate Studies.
Patients with chronic renal failure develop a “uremic” cardiomyopathy characterized by diastolic dysfunction, cardiac hypertrophy and systemic oxidant stress. Patients with chronic renal failure also are known to have increases in the circulating concentrations of the cardiotonic steroid marinobufagenin. On this background, we hypothesized that elevations in circulating marinobufagenin may be involved in the cardiomyopathy.First, we observed that administration of marinobufagenin (10 μg/kg/day) for 4 weeks caused comparable increases in plasma MBG as partial nephrectomy at 4 weeks. Marinobufagenin infusion caused increases in conscious blood pressure, cardiac weight and the time constant for left ventricular relaxation similar to partial nephrectomy. Decreases in the expression of the cardiac sarcoplasmic reticulum ATPase, cardiac fibrosis and systemic oxidant stress were observed with both marinobufagenin infusion and partial nephrectomy. Next, rats were actively immunized against a marinobufagenin -bovine serum albumin conjugate or bovine serum albumin control, and partial nephrectomy was subsequently performed. Immunization against marinobufagenin attenuated the cardiac hypertrophy, impairment of diastolic function, cardiac fibrosis and systemic oxidant stress seen with partial nephrectomy without significant effect on conscious blood pressure. These data suggest that the increased concentrations of marinobufagenin are important in the cardiac disease and oxidant stress state seen with renal failure.
Joseph Shapiro, M.D. (Committee Chair)
Deepak Malhotra, M.D., PhD (Committee Member)
Jiang Liu, PhD (Committee Member)
74 p.
Biology
marinobufagenin; fibrosis; cardiac; FLT-1

Recommended Citations

Citations

  • Vetteth, S. (2008). Central Role for Marinobufagenin in the Pathogenesis of Uremic Cardiomyopathy [Doctoral dissertation, University of Toledo]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=mco1229552226

    APA Style (7th edition)

  • Vetteth, Sandeep. Central Role for Marinobufagenin in the Pathogenesis of Uremic Cardiomyopathy. 2008. University of Toledo, Doctoral dissertation. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=mco1229552226.

    MLA Style (8th edition)

  • Vetteth, Sandeep. "Central Role for Marinobufagenin in the Pathogenesis of Uremic Cardiomyopathy." Doctoral dissertation, University of Toledo, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=mco1229552226

    Chicago Manual of Style (17th edition)

mco1229552226
543
© 2008, all rights reserved.
This open access ETD is published by University of Toledo Health Science Campus and OhioLINK.